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Abstract. Near-infrared imaging was used to quantify typical values
of hemoglobin concentration, oxygen saturation, water fraction, scat-
tering power, and scattering amplitude within the breast tissue of vol-
unteer subjects. A systematic study of the menstrual variations in these
parameters was carried out by measuring a group of seven premeno-
pausal normal women (aged 41 to 47 years) in the follicular (days 7 to
14 of the cycle) and secretory phases (days 21 to 28) of the cycle, for
two complete menstrual cycles. An average increase in hemoglobin
concentration of 2.6 mM or 13% of the background breast values was
observed in the secretory phase relative to the follicular phase (p
,0.0001), but no other average near-infrared parameter changes
were significant. While repeatable and systematic changes were ob-
served in all parameters for individual subjects, large intersubject
variations were present in all parameters. In a survey of thirty-nine
normal subjects, the total hemoglobin varied from 9 to 45 mM, with a
systematic correlation observed between total hemoglobin concentra-
tion and breast radiographic density. Scattering power and scattering
amplitude were also correlated with radiographic density, but oxygen
saturation and water fraction were not. Images of breast lesions indi-
cate that total hemoglobin-based contrast can be up to 200% relative
to the background in the same breast. Yet, since the background he-
moglobin values vary considerably among breasts, the maximum he-
moglobin concentrations observed in cancer tumors may vary consid-
erably as well. In light of these observations, it may be important to
use hemoglobin contrast values relative to the background for a given
breast, rather than absolute hemoglobin contrast when trying to com-
pare the features of breast lesions among subjects. © 2004 Society of Photo-
Optical Instrumentation Engineers. [DOI: 10.1117/1.1691028]
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Paper 044012 received Jul. 15, 2003; revised manuscript received Aug. 21, 2003;
accepted for publication Sep. 4, 2003.
1 Introduction
Near-infrared~NIR! imaging provides a method of quantify-
ing the spatial and temporal changes in breast tissue compo-
sition of features that provide contrast in this region of the
optical spectrum. While clinical breast imaging is performed
with x-ray mammography, ultrasound or contrast-enhanced
magnetic resonance imaging~MRI!, these standard imaging
modalities provide comparatively little information about
molecular-level changes in breast tissue. NIR imaging sup-
plies contrast information that is specific to oxyhemoglobin,
deoxyhemoglobin, and water, as well as scattering parameters
that are related to the microscopic fluctuations in refractive
index.1,2 Because of these unique contrast mechanisms, there
has been considerable interest in using NIR measurements to
Address all correspondence to Dr. Brian W. Pogue, Dartmouth College, Thayer
School of Engineering, 800 Cummings Hall, Hanover, NH 03755. Tel: 603-646-
3861; FAX: 603-646-3856; E-mail: pogue@dartmouth.edu 1083-3668/2004/$15.00 © 2004 SPIE
Journal of Biomedical Optics 9(3), 541–552 (May/June 2004)
Journal of Biomedical Optics d May/June 2004 d Vol. 9 No. 3 541
quantify changes in breast physiology or transition to
pathology.3,4 In this study, a clinical prototype NIR tomogra-
phy system was used to quantify average breast properties in
premenopausal and postmenopausal women, and to examine
the typical spatial fluctuations observed when imaging breasts
with lesions.
The origin of contrast in medical imaging systems can pro-
vide insight into the detection limits of normal and pathologi-
cal tissues. For imaging breast tumors, mammography is the
front line for screening and diagnostic purposes and relies
upon low-energy x-rays~10 to 30 keV! that have a contrast
based upon the structural matrix of soft tissue, owing largely
to changes in collagen or calcium deposits. As is illustrated in
Fig. 1~a!, these wavelengths have a dominant interaction with
water and tissue that is due to the photoelectric effect and
Compton scattering; hence, a change in the density of bulk
materials having a high atomic number typically causes con-
trast. These changes in bulk tissue composition are typically
small and lead to a maximum tumor-normal tissue contrast of
10%, as illustrated in Fig. 1~b!.5 Since mammography has
become the main line for clinical cancer screening, there has
been an enormous volume of investigation into the typical
patterns of contrast visible in the normal breast, and how tis-
sue radiographic composition varies in individual women.6–9
Similarly, intrinsic contrast with MRI10 or ultrasound typically
shows less than 10% variation,11 even when imaging tumors
within the normal tissue background, as illustrated in Fig.
1~b!. The contrast can be increased by either log compression
of the scale, as in ultrasound, or with injected contrast agents
such as gadolinium, as in MRI.
NIR contrast mechanisms and signal propagation in tissue
are quite different than other clinical imaging modalities. NIR
photons are completely dominated by elastic Mie-like scatter-
ing in tissue, as shown in Fig. 1~a!, and contrast variations in
this scattering are also generally small, on the order of 10 to
20%, as with Compton scattering. However, because the scat-
tering causes photons to follow a diffuse path in tissue, owing
to multiple elastic scattering events, changes in absorption
coefficient are amplified in the final signal because of an in-
creased path of travel. In addition, absorption contrast in tu-
mors is largely based upon concentration variations in blood
and water relative to the surrounding tissue, and the absorp-
tion ratio between tumor and normal breast tissue is perhaps
one of the highest intrinsic biological contrasts available in
medical imaging, being assessed up to 200% based upon the
level of vessel formation in the tumor.1,3,12,13Thus the combi-
nation of high absorption contrast and increased photon path
length from scattering contributes to a high intrinsic optical
contrast when diffuse light is used. Of course the benefit of
this enormous contrast is diminished somewhat by multiple
elastic scattering, reducing the achievable resolution to near 5
mm within a few centimeters of tissue. In fact, studies have
suggested that because of the dominance of scattering, further
increases in contrast would most likely not provide signifi-
cantly improved resolution. However, a review of the litera-
ture indicates that while a major focus on breast NIR imaging
has been established, there is comparatively little information
on typical variations in breast tissue optical properties and
how they change temporally in an individual. Histological
studies of breast physiology14,15 have shown that mitotic ac-
tivity is significantly affected by hormone variations during
the menstrual cycle, with peaks occurring in the second half
of the cycle, having maximum values near 20 to 26 days and
minimums near 6 to 8 days into the cycle. Similarly, MRI
imaging16,17has shown that cyclic variations are observable in
water volume, with glandular tissue volumes peaking in the
second phase of the cycle, although the magnitude and sig-
nificance of these changes are quite variable among
subjects.17 Studies with gadolinium-enhanced MRI for char-
acterizing breast lesions have shown that parenchymal en-
hancement does not occur as strongly in the beginning or
latter parts of the cycle,18 which has led to the recommenda-
tions that this type of imaging take place 1 to 6 or after 21
days into the cycle in premenopausal women. If similar varia-
tions are observed in NIR imaging, as recent studies have
indicated,2,19 it will be important to establish how these
changes affect image quality and diagnostic capabilities.
Fig. 1 The graph in (a) shows the dominant interactions between pho-
tons and water across the medically useful electromagnetic spectrum.
In x-ray mammography, the photon energies involved are near 2
3104 eV (10–30 keV), and thus Compton scattering and the photo-
electric effect are dominant in producing the contrast in the images. In
near-infrared imaging, near the 800-nm wavelength region, the domi-
nant interaction is Mie scattering (dotted line) of photons from intrac-
ellular fluctuations in the refractive index, which is about 100 times
greater than in Compton scattering. The absorption that is due to wa-
ter is quite low in comparison, and so the light transport in this wave-
length region is diffuse, owing to the random walk of photons in a
highly scattering region. The graph in (b) shows the tradeoff between
resolution and contrast in imaging tumor tissue in the breast. Mam-
mography, ultrasound, and MRI all have higher resolution, but the
intrinsic contrast available is low. In comparison, NIR imaging has
exceptionally high intrinsic contrast, but suffers from lower spatial
resolution because of diffuse light scattering.
Pogue et al.
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In this paper, a clinical prototype NIR tomography system
is described and the results of measurements in a series of
women are reported. The goal is to report on the intersubject
variability both before and after menopause, and to quantify
the intrabreast variation in properties observed in normal
breasts, which is compared with specific lesions imaged with
the system in order to establish the feasibility of detecting
and/or characterizing cancer lesions. In addition to the goal of
imaging cancer with NIR, there may be a role for these types
of measurements in normal breast tissue, either as a method of
characterizing tissue composition, changes in composition,
hormonal status, vascular disease, or lymph node changes.
Until a solid understanding of the normal tissue variation is




The clinical prototype imaging system is shown in Fig. 2 and
is currently being used in a clinical trial to determine its effi-
cacy in characterizing breast lesions. Figure 2~a! shows a
drawing of the hardware subsystems for light generation and
detection as well as the stage used to rotate the light source
around the fibers that encircle the breast. The photograph in
Fig. 2~b! shows the circular tissue–fiber interface that is
mounted on sixteen linear translation stages, allowing cou-
pling of the fibers to the breast surface in any diameter be-
tween 45 and 200 mm. The breast~or calibration phantom! to
be imaged is circled uniformly by the interface of three layers
of sixteen silica glass fibers of 6-mm diameter each. The
larger opening size of 200 mm is mainly used to allow easy
placement of the breast in the array. In order to transmit and
detect light through the breast, the opening generally has to be
120 mm or less in diameter at the time of tomography mea-
surement. All of the sources and detectors uniformly contact
the breast and force transducers are located in the array to
allow online measurement of the pressure applied to the tissue
surface. This feature was initially added as a safety measure,
but we later realized that the pressure-induced changes in
breast tissue optical properties are significant and need to be
featured in when imaging with NIR.20 In Fig. 2~c!, the system
is shown with the exam table covering the imaging array,
while in Fig. 2~d! a patient is lying prone on the table with the
breast to be imaged pendant through the opening.
Inside the optical subsystem, near-infrared light from six
laser diodes is used serially as the source, with average power
of more than 30 mW each, and wavelengths of 661, 761, 785,
808, 826, and 849 nm. The source wavelength is interchanged
using a high-power radio frequency~rf! switch for the driving
current. The driving current contains both direct current and rf
components, with the rf modulated by a function generator
Fig. 2 (a) An engineering drawing of the optical source and detection subsystem. The upper circular region holds three rings of sixteen fiber bundles
each, mounted to sixteen linear translation stages. The tomography imaging is achieved by cycling the laser source into each fiber sequentially,
through the circular translation stage on the bottom. While the laser is cycled into each fiber, the remaining fifteen fibers align with photomultiplier
tubes to allow detection of the transmitted light. Similarly to x-ray CT, the source and detector array rotate together, but in this geometry the tissue
is physically remote from the rotating gantry because the light is delivered via multiple fiber bundles. (b) A photograph of the same optical
subsystem, with a tissue contact ring; linear translator motors; a vertical translation stage that allows the entire array to be moved up or down;
overall motor controller panel; and the optical tomography source–detector rotation system. (c) The patient examination table with the optical
subsystem located immediately beneath the central hole in the table. (d) A female subject positioned on the table with her breast in the imaging
array.
Characterization of hemoglobin, water, and near-infrared . . .
Journal of Biomedical Optics d May/June 2004 d Vol. 9 No. 3 543
with a frequency of 100 MHz. The light is sequentially deliv-
ered to the breast through one of the sixteen fibers. The dif-
fusely transmitted light is detected by the remaining fifteen
fibers that are aligned to output to each of 15 photomultiplier
tube detectors that sample the signal in parallel. The electrical
signal outputs from the photomultipliers are heterodyned
down to 500 Hz, filtered and sampled by a 64-channel 200-
kHz analog to digital~A/D! board in the computer. A single
measurement at all detectors for one source location requires
approximately 0.5 s, and the complete measurement for all six
wavelengths at all source–detector pairs requires approxi-
mately 5 min. A complete discussion of this system and its
technical specifications is given elsewhere.21
2.2 Theory and Software
Light transport in tissue can be modeled with many different
approaches, including Maxwell’s equations, Mie scattering, or
radiation transport theory. It is well established for near-
infrared wavelengths interacting in tissue that scattering
dominates over absorption, and that the scattering interaction
is characterized by elastic processes resulting from refractive
index fluctuations at the microscopic level of cellular or-
ganelles. Under these complex circumstances, the Boltzmann
transport equation has been the most useful approach for
modeling over large tissue distances. This equation can be
simplified to the diffusion approximation when the radiation
concerned is neutrally charged and when it is dominated by
elastic scattering.22,23 Frequency-domain light measurements
have been implemented perhaps more successfully than time-
domain or continuous-wave methods, owing to their simplic-
ity while providing a unique dataset that allows estimation of
both absorption and scattering coefficients. In this case, the
phase shift of the signal provides a measurement that is domi-
nated by the optical path length through the tissue, while the
amplitude of the traveling wave provides information about
the overall attenuation of the signal. In addition, the lock-in
detection capabilities of frequency-domain hardware make
this type of system very reliable, robust, and efficient. The
theoretical analogue of this hardware approach is to model the
diffusion equation in the frequency domain, given by:
2¹•D~r !¹F~r ,v!1S ma1 ivc DF~r ,v!5S0~r ,v!,
~1!
whereS0(r ,v) is an isotropic source,F(r ,v) is the photon
fluence rate at positionr , andD(r )5$3@ma(r )1ms8(r )#}
21






wherea is a term that incorporates reflection as a result of
refractive index mismatch at the boundary andˆ is the
outward-pointing normal to the boundary. The data are repre-
sented by a nonlinear operator,f, which is a complex-valued
vector having a real and imaginary components, which is ac-
tually utilized as logarithm of the amplitude and phase in the
measurements. The diffusion theory solution to the forward
problem is then a nonlinear functional estimate off, denoted
asF(ma ,D), which is also a complex-valued vector function
corresponding to the computed photon fluence rate at the de-
tector sites. Then the image reconstruction method uses a
Newton-minimization approach to seek a solution to
~m̂a ,D̂ !5minma ,Di@ f2F~ma ,D !#i , ~3!
where i•i represents the square root of the sum of squared
elements. The magnitude of this is sometimes referred to as
the projection error and provides a value for determining the
convergence of the iterative reconstruction algorithm. The
finite-element method~FEM! is used as a general and flexible
method for solving the forward problem in arbitrary geom-
etries. In the inverse problem, the internal optical property
distributions are recovered from boundary measurements,
yielding images ofma(r ) and D(r ) at all discrete points
within the field representing the tissue.
To find the solution to Eq.~3!, a Newton-minimization
approach is followed, as developed by Paulsen and Jiang.24,25
Briefly, a matrix equation that can be iteratively solved from
Eq. 3 is as follows,
Jdm5@ f 2~ma ,D !#, ~4!
wheredm is a solution update vector,dm5@dma ,dD#, which
includes separate information on the updates in absorption
and diffusion coefficients, respectively, andJ is the Jacobian
matrix ~sometimes called the sensitivity matrix! for the diffu-
sion equation solution. SinceJ is a nonsquare matrix, we
multiply by the transpose, and becauseJTJ is an ill-
conditioned matrix, we require significant regularization in
order to invert it. Thus the final matrix equation becomes
~JTJ1kI!dm5JT@ f 2F~ma ,D !#. ~5!
The regularization parameter,k, is implemented in a
Levenberg-Marquardt algorithm where it starts at a high value
~typically 100! and is systematically reduced at each iteration.
This iterative solution must be completed with the following
matrix equation:
dm5~JTJ1kI!21JT@ f 2F~ma ,D !#. ~6!




i , andDi 115Di1dDi , wherei is the in-
dex for the iteration number. Also, the value of the Jacobian
matrix is updated at each iteration in order to provide a cor-
rection to the sensitivity matrix for changes in the coefficient
maps. A significant change to Eq.~6! was introduced by
Dehghani26 by adding the adjoint method of calculating the
Jacobian, and using the Moore-Penrose pseudoinverse instead
of the direct inverse.
The FEM reconstruction program is based on the
frequency-domain diffusion equation and allows recovery of
images ofma andms8 from the measured data. The FEM so-
lution of the diffusion equation on a circular mesh determines
a dataset calculated from an initial estimate of the average
optical properties(ma ,ms8) obtained from a calibration proce-
dure. In order to initiate the Newton-Raphson minimization
with Levenberg-Marquadt regularization, an initial estimate of
the optical properties is obtained from a separate minimiza-
tion algorithm. The accurate implementation of an initial es-
Pogue et al.
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timate has been found to be essential for achieving a good
solution to the image recovery problem described here. This
homogeneous estimate uses the same forward FEM solver,
but with the data averaged over all source positions and the
assumption of homogeneousma andms8 throughout the circu-
lar mesh. The details of the reconstruction program and ho-
mogeneous fitting algorithm can be found elsewhere.26–28
2.3 Spectral Decomposition Software
An important feature of NIR imaging is the ability to provide
information about different absorbing molecules and scatter-
ers within tissue. When spectral analysis is used with NIR
imaging, a number of chromophores can be deconvolved, as-
suming that a sufficient number of wavelengths are measured
to provide the information required. In single-point measure-
ment systems such as those demonstrated by Cerussi et al.,1
Shah et al.,2 and Tromberg et al.,29 it is relatively easy to
sample multiple wavelengths and solve for the concentrations
of chromophores present. If the absolute absorption coeffi-
cient at any wavelength can be calculated based upon a dif-
fusion theory analysis of the data, then this coefficient is as-
sumed to be a linear combination of the absorption that is due
to all relevant chromophores in the sample, each having a





«~ i ,l!Ci , ~7!
whereC is the concentration of each chromophore, with in-
dex i , under the assumption that there are onlyN relevant
chromophores present in the tissue at wavelengthl. In Fig.
3~a!, the absorption coefficient spectra of oxyhemoglobin, de-
oxyhemoglobin, and water are shown over the relevant wave-
length range used here, assuming concentrations of 0.5, 0.5,
and 30%, respectively, as a percent volume of the whole tis-
sue. A linear combination of these spectra is used to match the
measured absorption coefficient spectra at the six discrete
wavelengths in order to determine the estimated concentra-
tions of each chromophore.
When this spectral analysis is applied to tomographically
reconstructed images, it requires that a spectrum of values for
ma,k(l) be obtained for all pixels within the image, using
index ‘‘k’’ for the pixel number. Thus at every pixel location,
the linear inversion of Eq.~7! must be calculated to determine
the array ofCi values, given a well-known set of« i(l) for
the relevant chromophores, leading to the matrix equation:
Ck5E
21ma,k , ~8!
where C is now a vector of chromophore concentrations at
each pixel locationk; E is the matrix of molar extinction
coefficients having elements«( i ,l j ), for each of theN chro-
mophores atj and wavelengthl j ; and ma is the vector of
absorption coefficients at each wavelengthl for each pixel
locationk. Applying this approach with an unconstrained lin-
ear fitting to matrix Eq.~8!, we used multispectral tomogra-
phic data to derive images of oxyhemoglobin and deoxyhe-
moglobin. Clinical trials studying the value of hemoglobin
and water images are under way to determine the accuracy
and diagnostic value of these functional maps.
The scattering spectrum of tissue provides information
about the nature of the scattering particles and hence the com-
position of the tissue. Since the scattering occurs predomi-
nantly from Mie-sized particles, it has been observed that the
general trend in a scattering coefficient is to decrease subtly
with increasing wavelength, and that this curve is well fit by a
power law of the type:
ms8~l!5Al
2SP, ~9!
whereA andSPare arbitrary model parameters for amplitude
and scattering power, respectively.1,30,31 In this situation, as
the scattering centers decrease in size, the value ofSP in-
creases significantly, because the scattering takes on a shape
more indicative of Rayleigh scattering, whereSP54 is well
established. As the scattering objects become larger sizes,
with dimension@l, the value ofSP decreases to zero. In
tissue, typical values range between 0.1 and 0.3.32,33In the 1%
Intralipid solutions that are used to mimic the scattering of
soft tissues, the value isSP50.24.30 Typical scattering spec-
Fig. 3 Measurements from breast tissue have indicated that in the
wavelength band of 650 to 850 nm, the dominant contributions to
absorption are oxyhemoglobin, deoxyhemoglobin, and water, and
representative absorption spectra are shown for each of these in (a) to
illustrate their contribution to the overall absorption coefficient mea-
sured at each wavelength. The scattering spectrum is more difficult to
relate to specific tissue characteristics, so spectral decomposition into
structural features is generally not possible. However, fitting spectra to
a model function that approximates Mie theory provides a useful sum-
mary of the overall scattering features of tissue. (b) Reduced scattering
coefficient values at six wavelengths are shown, along with the model
function fit to the data.
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tral values at the six measurement wavelengths are shown in
Fig. 3~b!, along with the least-squares fit of Eq.~9! to the data.
One of the major structural features of breast tissue is the
large adipose fraction typically near the periphery of the
breast, which is thought to be an average of nearly 75% in
women. However, a large variation exists among individuals,
based on body mass index and breast size.34 In the interior of
the breast there is often glandular tissue, which has a higher
blood content and hence higher water content. This area is
thought to have a higher scattering power, perhaps owing to
smaller scattering sites, although the origin of the scattering
has not been established clearly.34 In areas of adipose tissue
where fat content is high, the scattering power is lower, again
perhaps because of the larger scattering centers of the lipid-
filled cellular space. In our images of scattering power, we see
this trend in most cases, where the scattering power is highest
in the interior of the breast and decreases toward the exterior.
Further study of the scattering power and its ability to predict
valuable information about the tissue is needed.
2.4 Human Subject Studies
Over the past 6 years, NIR spectral imaging has been used to
analyze breast composition from more than 120 female sub-
jects, with approximately half being normal and half being
abnormal.35,36 In this paper we present analyses from a se-
lected subset of the normal subject imaging exams in order to
interpret the breast changes and intersubject variability with
an eye toward comparing these results with findings from ab-
normal subjects findings. The clinical examination protocol
was approved by the institutional committee for the protection
of human subjects, and written consent was obtained from all
participating women. The age range of the subjects recruited
was typically 40 to 80 years, but a few participants outside
this age range were examined. The results from representative
breast images where cancer tumors were present are shown.
The majority of the recent images are part of a blind clinical
trial assessing the ability of NIR imaging to detect and char-
acterize breast lesions, and so only representative abnormal
cases can be presented here prior to completion of the study.
A subset of seven women who were premenopausal was
studied in detail to examine the physiological variations in the
breast that are due to menstrual cycle changes. These women
were specifically chosen to have ACR1 mammograms and
heterogeneously dense breast tissue, and were not taking any
hormone replacement therapies. The age range was from 41 to
47, with an average of 45 years. These women were imaged at
two time points during their menstrual cycle over two com-
plete cycles, providing four sets of images, with two during
the first phase~follicular! and two during the second phase
~secretory! of their cycle. Images of total hemoglobin, oxygen
saturation, water fraction, scattering power, and scattering am-
plitude were generated.
A second subset of 39 women who had normal mammo-
grams~ACR1 category! was imaged to examine the intersub-
ject variation in normal breast tissue properties. In prelimi-
nary studies,34,36 it was observed that there is a strong
correlation between radiographic density categorization and
certain NIR parameters. We followed up this observation to
specifically examine variation with breast density in this
larger subset of our clinical exams. The participants had a
range of differing radiographic densities and were classified in
one of four categories:~1! fatty, ~2! scattered,~3! heteroge-
neously dense, and~4! extremely dense. None of these sub-
jects were known to have any form of breast disease at the
time of examination. Classification and reading of mammo-
grams were completed by two expert radiologists in the
Breast Imaging Center of the Dartmouth Hitchcock Medical
Center. Radiographic density was assessed from all three pro-
jection images from mammography, and the classification was
made from assessment of the entire composition of the breast.
The NIR breast examinations were carried out following pro-
cedures described elsewhere.35,36
3 Results
3.1 Typical NIR Images In Vivo
Imaging of women with abnormal mammograms has indi-
cated that some lesions present increases in hemoglobin rela-
tive to the background tissue and relative to the contralateral
breast tissue. A typical image from one breast of a subject is
shown in Fig. 4, where a lesion was diagnosed from both core
needle biopsy and excisional analysis to be a ductal carci-
noma in situ with a size of 5 to 10 mm. In Fig. 4, a single
plane is shown where the presence of the lesion is observable
in the middle top of the hemoglobin image. Other features
also exist in the image, which are most likely associated with
glandular tissues, although they require further study to con-
firm their composition. Six images of absorption coefficient
and reduced scattering coefficient were reconstructed for this
plane, and the resulting spectral fits produce the images of
total hemoglobin, oxygen saturation, water fraction, scattering
amplitude, and scattering power, which are all contained in
Fig. 4. This spectral imaging was completed for two planes in
the symptomatic breast and one plane in the contralateral
breast. The full set of images of hemoglobin is shown in Fig.
5, where the presence of the lesion is strongest in the image
shown in Fig. 5~b!. The image of the contralateral breast in
Fig. 5~c! shows that localized heterogeneities are all signifi-
cantly lower than that observed in the symptomatic breast.
This type of imaging was completed on a large number of
subjects, and subsets of the imaging groups were analyzed for
interpretation of variation within subjects and among subjects.
Colocalized MRI and NIR imaging is also being developed to
help determine the origin of other spectral features that appear
in the images. In this case, the localized tumor appears with
100 to 200% contrast relative to the background, depending
upon the assumptions used to define the background.
3.2 Menstrual Cycle Studies
The premenopausal group of seven subjects was studied over
four successive visits in which two exams occurred during the
follicular phase of the cycle~7 to 14 days of the cycle; phase
1! and two exams during the secretory phase~21 to 28 days of
the cycle; phase 2!. Three planes~separated by 1 cm! along
the breast from the chest wall toward the nipple were mea-
sured in a single positioning of the fiber array. A set of mea-
surements was obtained from each breast, providing a total of
six planes of information. The data for total hemoglobin from
each plane of each subject were acquired sequentially and are
plotted in Fig. 6, where the values for phase 1 are plotted
against the corresponding values for phase 2. There is a large
variation, but there is a significant trend of increasing hemo-
Pogue et al.
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globin in the second phase, by 2.6mm, or 13% of the average
hemoglobin concentration in the breast(p,0.0001,with a
paired Student’st-test!. The seven individual hemoglobin
changes are plotted in Fig. 7 and were 0.67, 0.76,20.3, 5.7,
21.3,4.35, and 0.50mm, or 3.7, 2.9,21.2,28.9,25.6,21.7,
and 2.2% of the phase 1 values. Quantitative analysis of the
average changes in oxygen saturation, water fraction, scatter-
ing power, and scattering amplitude did not demonstrate any
statistically significant differences between the phase 1 and
phase 2 measurements when all subjects were grouped to-
gether. The individual differences for each subject are plotted
in Fig. 7 for these four quantities.
3.3 Normal Intersubject Variation
A subset of our data from imaging subjects over several years
was used to examine the variation in NIR properties among
women, based on using radiographic density as a surrogate
marker of tissue composition. A group of thirty-nine subjects
was used to plot values for the different radiographic densi-
ties, as shown in Fig. 8. The radiographic densities of~1!
fatty, ~2! scattered,~3! heterogeneously dense, and~4! ex-
tremely dense are denoted by different symbols in these
graphs. There was no ability to separate radiographic densities
based upon oxygen saturation, but hemoglobin values are sig-
nificantly different between groups 1 and 3, 1 and 4, 2 and 3,
and 2 and 4(p,0.001). Scattering power is also significantly
different between groups 1 and 2, 1 and 3, 1 and 4, 2 and 3,
and 2 and 4(p,0.05). Unfortunately there were probably
not enough subjects in the extremely dense category to allow
sufficient statistical power when comparing groups 3 and 4. It
is interesting though, if groups 1 and 2 are taken together as
low density, and groups 3 and 4 are taken together as high
density, then hemoglobin, scattering power, and scattering
amplitude are all significantly different among these densities
(p,1024). Conversely, the values for oxygen saturation and
water fraction are quite scattered in each category and are not
significantly different based upon breast radiographic density.
The absolute value averages for all NIR properties and asso-
ciated standard deviations are shown in Table 1, separated
into the four groups of radiographic densities.
4 Discussion
Hemoglobin imaging can provide very high contrast for cer-
tain types of lesions. Because the dominant factor causing
absorption is hemoglobin, the fraction of hemoglobin or the
functional vessel density of a tissue defines the absorption-
based attenuation that will be detected. The relative difference
between a tissue to be imaged and its background defines the
available contrast, and based upon the data shown here and
our experiences described in previous publications,1,13,35,37,38
it appears that the total hemoglobin contrast is nearly 100 to
200% for cancer tumors within the background of normal
breast tissue. This contrast level is extremely high, perhaps
higher than the intrinsic contrast of any other imaging modal-
ity used today. Of course this ultrahigh contrast is offset by
the modest spatial resolution that can be achieved with NIR
image reconstruction. Because of the diffuse light path that is
Fig. 4 The images in this figure are reconstructed from frequency-domain NIR measurements through one plane of a woman’s breast. The images
in the top row show absorption coefficient estimates at all six wavelengths of 661, 761, 785, 808, 826, and 849 nm. The images in the middle row
show the corresponding reconstructions of the reduced scattering coefficient at all six wavelengths. The five images in the bottom row have been
calculated from spectral fitting of the middle row images, to estimate total hemoglobin, oxygen saturation, water fraction, and scattering amplitude,
and scattering power.
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taken between source and detectors, it appears unlikely that
major advances in the spatial resolution will occur in the near
future. Perhaps one of the most promising directions for im-
proving spatial resolution is to couple the NIR reconstruction
to another modality that provides higher structural informa-
tion, such as ultrasound, computed tomography~CT!, or MRI.
Investigations into MRI-guided NIR imaging are under way
and should reveal potential solutions for improving resolution.
Another factor of importance in evaluating NIR imaging is
assessment of tumor contrast relative to the typical variations
observed in normal tissues, both longitudinally over time as
well as among different women. In this study we have been
able to quantify the bulk average values of subjects in both of
these terms, and can estimate changes related to menstrual
cycle variations and inherent compositional differences as re-
flected by radiographic density.
Menstrual cycle changes in breast composition are gener-
ally accepted, yet quantitative measurements of these changes
are somewhat less traceable. While these changes have been
known qualitatively, Vogel et al.39 quantified the variations
from histological examination of normal breast tissue re-
moved from women. The specific phases of the cycle are~1! a
proliferative phase~days 3 to 7!, ~2! a follicular phase of
differentiation~days 8 to 14!, ~3! a luteal phase of differentia-
tion ~days 15 to 20!, ~4! a secretory phase~days 21 to 27!, and
~5! a menstrual phase~days 28-2!. Vogel found that changes
consistent with reduced metabolism are observed in the folli-
cular phase, whereas increased metabolic activity is observed
in the secretory, menstrual, and proliferative phases.
In our study, the subjects were examined in the follicular
phase~called phase 1 here! and in the secretory phase~called
phase 2 here!. The menstrual cycle changes observed for he-
moglobin concentration are in reasonably good agreement
with those of parenchymal cellular proliferation increasing in
phase 2 of the menstrual cycle, as observed by Potten et al.15
and Going et al.,14 and with a maximum average increase in
fibroglandular tissue volume of 10% observed by Graham
et al.17 Here, there was a 13% overall average change in total
hemoglobin. As observed by Graham et al., there was consid-
erable intersubject variation in these changes, indicating that
it is most likely difficult to make generalized observations
about the average tissue changes. It is possible that certain
subjects consistently exhibit larger variations than others;
however, further study of the magnitude and repeatability of
these changes would be required to confirm this hypothesis.
Since whole breast values were quantified here, it is likely
that increases in hemoglobin would be correlated with in-
creases in fibroglandular breast volume since this is the frac-
tion of the breast that has the most dominant vascularity.
In interpreting our menstrual cycle variation data here, it is
important to note that the age range of these seven subjects
Fig. 5 Images from the same subject as in Fig. 4 showing in (a) and (b)
total hemoglobin maps for two planes in the symptomatic breast and
(c) for one plane imaged from the contralateral breast. Image (a) was
above the plane of the abnormality while image (b) was in the plane
of the abnormality. Fine-needle and excisional biopsies confirmed
that the lesion near the bottom of image (b) was a ductal carcinoma in
situ.
Fig. 6 Menstrual cycle variations in tissue composition were mea-
sured in seven subjects, within three planes in each breast, during the
first and last phases of the menstrual cycle. Each woman was followed
through two menstrual cycles, and the data on total hemoglobin esti-
mate are shown for each subject in each plane in each breast. The
clustering of the data above the line illustrates that there is a signifi-
cantly higher hemoglobin concentration in the breast in the second
phase of the cycle, when all data are compared with a Student’s t-test
(p,1025).
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was 41 to 47 with an average age of 45, so they were actually
all quite close to menopause age. Thus it is reasonable to
expect that a younger group of subjects might exhibit stronger
and overall more systematic fluctuations in breast composi-
tion. Nonetheless, we specifically chose this age range for our
subjects because it is the relevant age for patients who are
likely not to receive routine mammography screening, but are
at a higher risk of developing breast cancer. Further studies of
menstrual cycle variations in younger women are important to
augment what is presented here. Finally, it is important to note
that the changes were most dominant in only two subjects,
whereas of the other five, three were positive but not signifi-
cant alone and two were negative changes but not significant
alone. These data are in relatively good agreement with the
individual cases presented by Shah et al.2 and Cubbedu
et al.,19 where in the Shah data the individual patient’s total
hemoglobin varied from 3.1 to 4.7mM in the cycle and in the
Cubbedu study the total hemoglobin varied from near 48 to
near 80mM, when transmission data were used. The intersub-
ject variations observed appear to be high in all studies, and
thus the heterogeneity of changes among subjects is an impor-
tant issue and one that will likely require the study of large
numbers of subjects in order to reach useful conclusions.
As part of the second goal of this paper, we wanted to be
able to quantify the typical range of variations observed in
normal subjects for hemoglobin, oxygen saturation, water,
and scattering. These variations are plotted in Fig. 8 for a
subset of thirty-nine normal subjects who were imaged. They
were divided into different radiographic density categories~1
through 4! simply to provide an initial grouping of breasts
with specific tissue types. Since fatty tissue is likely to have
substantially different NIR chromophore composition than
dense fibroglandular tissues, radiographic density is a reason-
able criterion for grouping the breasts. In previous studies,
Shah et al.2 indicated that total hemoglobin values in a range
of subjects varied from 2 to 26mM on average, whereas
Cubbedu et al.19 indicated values nearer 35 to 80mM. Our
values fall within these large and widely varying ranges. The
average values listed in Table 1 can be used to interpret how
much the background values of each quantity vary among
subjects. For example, variation among the hemoglobin in the
breast ranges from 9 up to 45mM in absolute range, or 15 up
to 30 mM for average values. This represents a very large
range of values, indicating that vascular density must vary
considerably among these breast density types. In contrast,
oxygen saturation varies over an absolute range from 30 up to
Fig. 7 In these plots, the absolute changes in (a) hemoglobin, (b) oxygen saturation, (c) water, (d) scattering power, and (e) scattering amplitude are
shown for each of the seven subjects. These values are reported as averages over all planes from both breasts, with the error bars showing the
standard error of the mean in each case.
Characterization of hemoglobin, water, and near-infrared . . .
Journal of Biomedical Optics d May/June 2004 d Vol. 9 No. 3 549
76%; and yet, average values for the different breast catego-
ries are all within the range of6062%, indicating that there
is no difference in breast tissue oxygenation based upon ra-
diographic density. However, other factors likely influence the
oxygenation differences among breasts. Further study of the
ability to use oxygen saturation as a useful parameter is most
likely required, perhaps with focus on the dynamics in re-
sponse to a stimulus, rather than the absolute value in a rest-
ing state.
A considerable amount of data are being developed on the
NIR properties of tumors, but assuming that the contrast is
largely due to blood volume in the tumor, it is relatively clear
that the contrast observed from a tumor in normal tissue will
be affected by the normal tissue values. In our studies of
tumors, it appears that cancer tumors have higher total hemo-
globin; however, a detailed analysis of the contrast available
needs to be carried out to see how much the intersubject
variation in total hemoglobin affects the ability to detect or
characterize changes in the total hemoglobin spatially. Thus,
as the large contrast is exploited to image and characterize
lesions within the breast, it will likely be essential to interpret
the changes in hemoglobin and other NIR parameters relative
to the background properties of the same breast and to avoid
numerical comparisons of the absolute values among breasts.
The large variation in scattering power and scattering am-
plitude among subjects with different radiographic densities is
interesting, and most likely is a measure of the dominant com-
positional changes among these different breast types.33 In
particular, the index of refraction and size of particles causing
scattering changes as the composition varies from a fatty one
to a glandular or a fibrous one. The exact features that con-
tribute to bulk scattering coefficients in tissue are extremely
hard to identify because these are contributions from a num-
ber of structural components of the tissue. However, it is clear
that there are significant changes in the scattering power and
amplitude as the bulk composition changes across different
radiographic densities. Further microscopic study of what
causes these changes would be an important line of research.
The strong correlation between radiographic density and
NIR parameters may possibly provide a useful tool for assess-
ing breast physiology and potential risks of disease. NIR spec-
troscopy has been used to classify tissues according to breast
density in larger population studies.40,41 Our results indicate
that the spectral features responsible for these correlations are
most likely predominantly due to hemoglobin and scattering
differences. Since the use of mammography has become the
primary form of clinical screening for breast disease in older
women, large epidemiological studies have demonstrated that
radiographic density is correlated to risk of developing breast
cancer.42,43 The reasons for this are difficult to determine and
a causal relationship has not been demonstrated, although
many studies are under way to examine the features of the
breast that are likely to be the origin of disease.44 It is a
challenge to elucidate the causal link between density and risk
of cancer because the tools to measure breast composition are
limited. In this context, near-infrared measurements do pro-
vide an independent measure of tissue, where the contrast is
based upon the elastic scattering of light and the absorption
that is due to molecules present, such as water and hemoglo-
Fig. 8 Average breast data from a group of normal subjects of mixed
pre- and postmenopausal status. The data are divided into the radio-
graphic density categories of (1) fatty, (2) scattered, (3) heteroge-
neously dense, and (4) extremely dense. (a) The oxygen saturation
from each breast is shown against the total hemoglobin in the same
breast. (b) The scattering power is plotted against the total hemoglobin
for the same subjects.
























1 (fatty) 15.465.3 59.5613 51.168.5 0.660.1 59625
2 (scattered) 16.064.7 61.569.4 43.168.7 0.460.1 16.466.5
3 (heterogeneously dense) 26.266.5 59.768.9 46.5612 1.060.4 8.9310262.73104
4 (extremely dense) 29.5612 61.368.6 65.862.3 1.360.6 9.3310361.83105
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bin. In addition, irrespective of the causal relationship be-
tween radiographic density and risk, mammography is the
main screening tool available for assessing the breast, and it is
becoming clear that women with breasts of higher radioden-
sity should probably be screened at an earlier age and perhaps
screened more frequently than those in a lower risk
category.45 If near-infrared imaging can be implemented in a
low-cost manner, then scanning subjects at an earlier age
would be feasible, potentially as a method to categorize the
tissue composition and risk of developing disease.
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